UPMC Presbyterian

1. Actelion Pharmaceuticals, Ltd $74,414 8 payments
2. Ipsen Pharma SAS $9,086 7 payments
3. Takeda Pharmaceuticals U.S.A., Inc. $4,500 1 payment
4. E.R. Squibb & Sons, L.L.C. $4,086 3 payments
5. Boehringer Ingelheim International GmbH $530 9 payments
6. KARL STORZ Endoscopy-America $156 1 payment

1. Triton - Ac-065A308 $39,234 4 payments
2. Ac-055-403 - Repair $35,180 4 payments
3. A Prospective Observational International Study of Cabozantinib Tablets in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma in Adults $5,047 4 payments
4. IIR-USA-001899 IIR-USA-001899 - The Effect of Teduglutide on the Utilization of Enteral Nutrients for the Synthesis of Hepatic, Pancreatic, and Mucosal Proteins $4,500 1 payment
5. A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity $4,039 3 payments
6. nHCM Phase III - A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy $2,780 1 payment
7. A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM) $727 1 payment
8. A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy $579 1 payment
9. A double blind, randomised, placebo-controlled trial evaluating the efficacy and safety of nerandomilast over 26 weeks in patients with Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Diseases (SARD-ILD) $530 9 payments
10. Enhanced Contact Endoscopy (ECE) in Pituitary Adenoma Surgery $156 1 payment

1. Other $156 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.